AMG-119
AMG-119 is a humanized IgG1 monoclonal antibody that targets delta-like ligand 3 (DLL3) . AMG-119 can be used for the study of relapsed/refractory (R/R) small cell lung cancer (SCLC) . Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001) [1].
Product Specifications
UNSPSC
12352203
Target
Notch
Related Pathways
Neuronal Signaling; Stem Cell/Wnt
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[AMG-119]
References & Citations
[1]Zhou D, et al. Clinical Pharmacology Profile of AMG 119, the First Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting Delta-Like Ligand 3 (DLL3), in Patients with Relapsed/Refractory Small Cell Lung Cancer (SCLC) . J Clin Pharmacol. 2024 Mar;64 (3) :362-370.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
868900-01 100 mL
Nickel (Ni) 1000 ppm Single Element Std. Soln. for ICP in HNO3 Nist Traceable
Ask
View Details 
868900-02 500 mL
Nickel (Ni) 1000 ppm Single Element Std. Soln. for ICP in HNO3 Nist Traceable
Ask
View Details 
268384-01 5 mg
3- (2-Chloroethyl) -6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
Ask
View Details 268384-02 10 mg
3- (2-Chloroethyl) -6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
Ask
View Details 268384-03 25 mg
3- (2-Chloroethyl) -6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
Ask
View Details